Literature DB >> 22552741

CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.

Sang Hyuk Cho1, Yeon Sun Park, Hun Jin Kim, Chang Hyun Kim, Sang Woo Lim, Jung Wook Huh, Jae Hyuk Lee, Hyeong Rok Kim.   

Abstract

The metastatic process involves the migration and invasion of cancer cells throughout the body to produce secondary tumors at distant sites. Through of epithelial-mesenchymal transition (EMT), cancer cells employ developmental processes to gain migratory and invasive properties. CD44 is the transmembrane adhesion receptor for Hyaluronan (HA) and plays a central role in the remodeling and degradation of HA that leads to cell migration, as well as to cancer invasion and metastasis. CD44 is highly expressed in primary and metastatic colon cancer but lowly expressed in normal tissues. We evaluated the impact of CD44 on EMT and invasion of colon cancer cells. The functional role of CD44 in EMT was determined by the overexpression or knockdown of CD44. CD44 was overexpressed by transfection with plasmid-RT-PCR product and knockdown of CD44 by small hairpin RNA (shRNA)-mediated depletion of CD44 in SW480 colon cancer cells. Morphological changes were evaluated by confocal laser microscopy in the culture media. The expression of EMT markers (E-cadherin/N-cadherin/vimentin/fibronectin/actin/MMPs) and CD44/EGFR/PI3K-Akt signaling were evaluated using western blotting. The influence of EMT in tumor biology was assessed with proliferation, migration and invasion assays. EMT changes increased in CD44-overexpressing SW480 cells and decreased in CD44 knockdown cells. CD44 activation induced expression of EGFR and activation of phosphatidylinositol 3' kinase (PI3K)/Akt and expression of glycogen synthase kinase-3 β (GSK-3β). In terms of EMT markers, CD44 downregulated E-cadherin expression, upregulated N-cadherin, α-actin, vimentin, fibronectin and MT1-MMP, and inhibited the formation of the membrane-associated E-cadherin-β-catenin complex, which resulted in cell invasion and migration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552741     DOI: 10.3892/ijo.2012.1453

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  63 in total

1.  Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.

Authors:  Naris Nilubol; Myriem Boufraqech; Lisa Zhang; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2014-03-21       Impact factor: 5.958

Review 2.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

3.  Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.

Authors:  Meriam Ayadi; Anaïs Bouygues; Djamila Ouaret; Nathalie Ferrand; Salem Chouaib; Jean-Paul Thiery; Christian Muchardt; Michèle Sabbah; Annette K Larsen
Journal:  Oncotarget       Date:  2015-07-30

Review 4.  Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.

Authors:  Zhuang Luo; Rong-Rong Wu; Liang Lv; Peng Li; Li-Yan Zhang; Qing-Lin Hao; Wei Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach.

Authors:  Jasmine Naru; Ritu Aggarwal; Usha Singh; Ashok Kumar Mohanty; Deepak Bansal; Navdeep Mangat; Nandita Kakkar; Navneet Agnihotri
Journal:  Tumour Biol       Date:  2016-08-03

6.  Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.

Authors:  Guo-Li Gu; Xiao-Quan Zhu; Xue-Ming Wei; Li Ren; De-Chang Li; Shi-Lin Wang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

7.  Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells.

Authors:  Zhongwei Liu; Weimin Gao
Journal:  Toxicol Appl Pharmacol       Date:  2017-09-21       Impact factor: 4.219

8.  Breast carcinoma is a multifactorial disease involving FOXN3, SINA3 and NEAT through repression of GATA3 and TJP.

Authors:  Dina Sabry; Abeer Mostafa; Amira Hassouna
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

9.  Toward early detection of Helicobacter pylori-associated gastric cancer.

Authors:  Rachel Walker; Jan Poleszczuk; Jaime Mejia; Jae K Lee; Jose M Pimiento; Mokenge Malafa; Anna R Giuliano; Heiko Enderling; Domenico Coppola
Journal:  Gastric Cancer       Date:  2017-07-19       Impact factor: 7.370

10.  Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.

Authors:  Yanping Chen; Jinlian Song; Yuhong Jiang; Chundong Yu; Zhongliang Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.